Statutory Rules of Northern Ireland
Dangerous Drugs
Made
21st October 2014
Coming into operation
11th November 2014
The Department of Health, Social Services and Public Safety makes the following Order in exercise of the powers conferred by section 7(4) of the Misuse of Drugs Act 1971 (1) as adapted by section 7(9) of that Act and now vested in it (2) and after consultation with the Advisory Council on the Misuse of Drugs in accordance with section 7(7) of that Act.
1. (1) This Order may be cited as the Misuse of Drugs (Designation) (Amendment No.3) Order (Northern Ireland) 2014 and comes into operation on 11th November 2014.
(2) The Interpretation Act (Northern Ireland) 1954 (3) shall apply to this Order as it applies to an Act of the Northern Ireland Assembly.
2. (1) The Misuse of Drugs (Designation) Order (Northern Ireland) 2001 (4) is amended as follows:
(2) In paragraph 1(a) of Part 1 of the Schedule, after "Gamma-butyrolactone" insert-
"Khat"
Sealed with the Official Seal of the Department of Health, Social Services and Public Safety on 21st October 2014
Dr. Anne Kilgallen
A senior officer of the
Department of Health, Social Services and Public Safety
(This note is not part of the Order)
Section 7(3) of the Misuse of Drugs Act 1971 requires Regulations to be made to allow the use for medical purposes of the drugs which are subject to control under that Act. Section 7(3) does not apply to any drug designated by order under section 7(4) as a drug to which section 7(4) is to apply. This Order amends the Misuse of Drugs (Designation) Order (Northern Ireland) 2001 by inserting Khat into Part 1 of the Schedule to that Order.
1971 c.38 as amended by s.151 of and Schedule 17 to the Police Reform and Social Responsibility Act 2011 c.13.
S.R. & O. (N.I.) 1973 No.504, Article 5(a) and S.I.1999/283 (N.I.1), Article 3(6)
S.R. 2001 No.431 relevant amending Orders are S.R. 2014 Nos. 159 and 20, S.R. 2013 No.77, S.R. 2012 No.212, S.R. 2011 No.154, S.R. 2010 Nos.149 and 246, S.R. 2009 No.389 and S.R. 2005 No.359